BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34148620)

  • 1. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer.
    Grady WM
    Adv Cancer Res; 2021; 151():425-468. PubMed ID: 34148620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.
    Grady WM; Yu M; Markowitz SD
    Gastroenterology; 2021 Feb; 160(3):690-709. PubMed ID: 33279516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and epitranscriptomic changes in colorectal cancer: Diagnostic, prognostic, and treatment implications.
    Porcellini E; Laprovitera N; Riefolo M; Ravaioli M; Garajova I; Ferracin M
    Cancer Lett; 2018 Apr; 419():84-95. PubMed ID: 29360561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
    Okugawa Y; Grady WM; Goel A
    Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
    Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
    Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique methylation pattern of oncostatin m receptor gene in cancers of colorectum and other digestive organs.
    Deng G; Kakar S; Okudiara K; Choi E; Sleisenger MH; Kim YS
    Clin Cancer Res; 2009 Mar; 15(5):1519-26. PubMed ID: 19223499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
    Toiyama Y; Okugawa Y; Goel A
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic biomarkers in colorectal cancer diagnostics.
    Rawson JB; Bapat B
    Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding colorectal cancer epigenomics.
    El Bairi K; Tariq K; Himri I; Jaafari A; Smaili W; Kandhro AH; Gouri A; Ghazi B
    Cancer Genet; 2018 Jan; 220():49-76. PubMed ID: 29310839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic Modifiers and Their Potential Application in Colorectal Cancer Diagnosis and Therapy.
    Shinde S; Saxena S; Dixit V; Tiwari AK; Vishvakarma NK; Shukla D
    Crit Rev Oncog; 2020; 25(2):95-109. PubMed ID: 33389860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation markers in colorectal cancer.
    Kim MS; Lee J; Sidransky D
    Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management.
    Deka D; Scarpa M; Das A; Pathak S; Banerjee A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1882-1894. PubMed ID: 33605866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics of colorectal cancer: biomarker and therapeutic potential.
    Jung G; Hernández-Illán E; Moreira L; Balaguer F; Goel A
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):111-130. PubMed ID: 31900466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.